F-Prime Capital Partners
VC
INVESTOR TYPE
Active
STATUS
25
PROFESSIONALS
260
INVESTMENTS
124
PORTFOLIO
69
EXITS
Description
F-Prime Capital Partners is a venture capital firm headquartered in Cambridge, Massachusetts. The firm seeks to make investments in firms focused in biopharmaceutical, medtech, healthcare service, enterprise information technology and fintech.
Website
Formerly Known As
Fidelity Biosciences
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1969
Primary Investor Type
Venture Capital
Primary Office
- 1 Main Street
- 13th Floor
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
F-Prime Capital Partners Investments (260)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Snapsheet | 20-May-2019 | Later Stage VC | 0000 | Automotive Insurance | Generating Revenue | 00000000 00000 |
| 00000 000000000000 | 07-May-2019 | 00000 00000 | 000.00 | Drug Discovery | Startup | 0000000 000000 00.0 |
| 0000000 | 02-May-2019 | 00000 00000 | 00.000 | Other Healthcare Technology Systems | Generating Revenue | |
| 000000 00000000000 | 18-Apr-2019 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 000000 | 10-Apr-2019 | 00000 00000 | 000.00 | Monitoring Equipment | Generating Revenue | 0000 00000 |
| 000 0000000000 | 08-Apr-2019 | 00000 00000 | 0000 | Therapeutic Devices | Product Development | 00000 00000 00 |
| 00000000 | 07-Apr-2019 | 00000 00000 | 000.00 | Network Management Software | Generating Revenue | 000000 0000 |
| 00000000 | 02-Apr-2019 | 00000 00000 | 0000 | Other Financial Services | Generating Revenue | 00000000 00000 |
| Kyruus | 15-Mar-2019 | Later Stage VC | 0000 | Information Services (B2C) | Generating Revenue | |
| Artemis Health | 14-Mar-2019 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue | 00000000 000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore F-Prime Capital Partners’s full profile, request a free trial.
F-Prime Capital Partners Exits (69)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Precision BioSciences | 28-Mar-2019 | IPO | 00000 | Completed |
|
| 00000 | 08-Jan-2019 | 000000000000000000 | 00000 | Completed |
|
| 00000000 000000000 | 31-Oct-2018 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 31-Oct-2018 | 000 | 00000 | Completed |
|
| 000 00000000 | 14-Sep-2018 | 000 | 00000 | Completed |
|
| 00000 (00000000) | 26-Apr-2018 | 000000000000000000 | 000.00 | Completed |
|
| 0000000 00000000 | 23-Apr-2018 | 000 | 00000 | Completed |
|
| 000000 00000000000 | 09-Apr-2018 | 000000000000000000 | 00000 | Completed |
|
| Mersana Therapeutics | 31-Mar-2018 | Secondary Transaction - Open Market | Completed |
|
|
| UNUM Therapeutics | 29-Mar-2018 | IPO | 000.00 | Completed |
|
F-Prime Capital Partners Team (61)
16 Former Team Members
You’re viewing 5 of 61 team members. Get the full list »F-Prime Capital Partners Co-Investors (445)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Eight Roads | 47 | 0 | 00 |
| ARCH Venture Partners | 0 | 0 | |
| GV | 0 | 0 | 0 |
| Cormorant Asset Management | 0 | 0 | 0 |
| OrbiMed | 0 | 0 | 0 |